T3018LMonarch reg RNase A
State & local contract award Virginia Awarded
- Contract number
- A236_P0342452
- Awardee
- New England Biolabs Inc
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $408.50
About this award
Virginia Commonwealth University awarded a contract to New England Biolabs Inc. on June 29, 2026, for the procurement of molecular biology reagents. The contract, identified as A236_P0342452, is valued at $408 and involves the delivery of five units of Monarch RNase A to VCU Procurement at the stated unit price of $81.70 per item. Virginia Commonwealth University serves as the contracting organization for this award in Virginia.
The line item specification calls for Monarch RNase A, a ribonuclease enzyme product, to be delivered to VCU Procurement. New England Biolabs Inc., the prime contractor, is responsible for fulfilling this product delivery requirement. The contract represents a straightforward procurement of laboratory reagents for use within the university's research and operational activities. No additional performance period details, annual value parameters, or cumulative funding thresholds beyond the stated contract amount of $408 were specified in the award documentation.
Line items
| Item | Total |
|---|---|
| T3018LMonarch reg RNase A | $408.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0342452?
Contract A236_P0342452 was awarded to New England Biolabs Inc by Virginia Commonwealth University on June 29, 2026.
How much is contract A236_P0342452 worth?
Its cumulative value is $408.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award